| CD63 |
CD63, MLA1, TSPAN30: CD63 antigen |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
15.080 |
Evidence |
|
| THBD |
THBD, THRM: Thrombomodulin precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
15.080 |
Evidence |
|
| THBD |
THBD, THRM: Thrombomodulin precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
15.080 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
15.080 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
SELE |
SELE, ELAM1: E-selectin precursor |
15.080 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
15.080 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
INSR |
INSR: Insulin receptor precursor |
15.080 |
Evidence |
|
| REG1B |
REG1A, PSPS, REG: Lithostathine 1 alpha precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
15.080 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
15.080 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
IRS1 |
IRS1: Insulin receptor substrate 1 |
15.080 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
F12 |
F12: Coagulation factor XII precursor |
15.080 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
SPTAN1 |
IPI00413728 |
15.080 |
Evidence |
|
| STAT3 |
|
SPTA1 |
SPTA1, SPTA: Spectrin alpha chain, erythrocyte |
15.050 |
Evidence |
|
| BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
STAT3 |
|
15.050 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
15.050 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
15.050 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
15.050 |
Evidence |
|
| SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
AKT3 |
AKT3: RAC-gamma serine/threonine-protein kinase |
15.050 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
15.050 |
Evidence |
|
| CNN2 |
CNN2: Calponin-2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
15.050 |
Evidence |
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
AKT3 |
AKT3: RAC-gamma serine/threonine-protein kinase |
15.050 |
Evidence |
|
| ELMO1 |
IPI00219532 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
15.050 |
Evidence |
|
| MYO3A |
MYO3A: Myosin IIIA |
STAT3 |
|
15.050 |
Evidence |
|
| MINK1 |
MAP4K6, MINK1, MINK: Misshapen-like kinase 1 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
15.050 |
Evidence |
|
| PKN1 |
PKN1, PKN, PRK1, PRKCL1: Serine/threonine-protein kinase N1 |
CCNB1 |
Cyclin B1 |
15.050 |
Evidence |
|